16-3137430-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004220.3(ZNF213):c.150A>G(p.Gln50Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,613,966 control chromosomes in the GnomAD database, including 112 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 59 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 53 hom. )
Consequence
ZNF213
NM_004220.3 synonymous
NM_004220.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.932
Publications
0 publications found
Genes affected
ZNF213 (HGNC:13005): (zinc finger protein 213) C2H2 zinc finger proteins, such as ZNF213, have bipartite structures in which one domain binds DNA or RNA and the other modulates target gene expression.[supplied by OMIM, Apr 2004]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 16-3137430-A-G is Benign according to our data. Variant chr16-3137430-A-G is described in ClinVar as [Benign]. Clinvar id is 785519.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.932 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0512 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF213 | NM_004220.3 | c.150A>G | p.Gln50Gln | synonymous_variant | Exon 2 of 6 | ENST00000396878.8 | NP_004211.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0155 AC: 2363AN: 152188Hom.: 59 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2363
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00417 AC: 1046AN: 250572 AF XY: 0.00308 show subpopulations
GnomAD2 exomes
AF:
AC:
1046
AN:
250572
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2484AN: 1461660Hom.: 53 Cov.: 31 AF XY: 0.00143 AC XY: 1041AN XY: 727138 show subpopulations
GnomAD4 exome
AF:
AC:
2484
AN:
1461660
Hom.:
Cov.:
31
AF XY:
AC XY:
1041
AN XY:
727138
show subpopulations
African (AFR)
AF:
AC:
1815
AN:
33480
American (AMR)
AF:
AC:
200
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
28
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53202
Middle Eastern (MID)
AF:
AC:
13
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
163
AN:
1112010
Other (OTH)
AF:
AC:
265
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
163
326
489
652
815
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0156 AC: 2372AN: 152306Hom.: 59 Cov.: 33 AF XY: 0.0149 AC XY: 1107AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
2372
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
1107
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
2203
AN:
41556
American (AMR)
AF:
AC:
119
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20
AN:
68026
Other (OTH)
AF:
AC:
29
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Oct 09, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.